Provista Diagnostics, Inc. is a privately held molecular diagnostics company focused on developing and commercializing a new generation of proprietary blood-based diagnostic, prognostic and monitoring tests designed to address the unmet needs in breast and gynecological cancers.

from http://www.provistadx.com/home/about-provista/

Research Grants show all

NIH2

Publications show all

Provista Diagnostics has published 3 articles.

Patents show all

12Applications1Issued

Clinical Trials show all

2N/A

SEC Filings show all

D7